Home Brain Tumors The IBTA e-News October 2020
Brain Tumors

The IBTA e-News October 2020

By wordpressadmin
0
67

Leading news

It’s International Brain Tumour Awareness Week!

This week marks International Brain Tumour Awareness Week (Saturday, 24th October 2020 to Saturday 31st October 2020), a celebration of awareness-raising activities in which the international brain tumour community unites to draw attention to the challenges of brain tumours and the need for an increased research effort.

We know how challenging it is to safely organise…

Continue Reading to the Source

Previous articleCause of Alzheimer’s disease traced to mutation in common enzyme
Next articleConducting a survey research, regarding Genetic tests for cancer. : braincancer
wordpressadmin

RELATED ARTICLES

Brain Tumors

How has COVID-19 affected the global cancer community? – IBTA

wordpressadmin - 0
Save the date: Coalition Connection: COVID-19 on 4 February 06:30am PST/ 09:30am EST/ 02:30pm GMT/ 03:30pm CET On 4th February 2021, the Global Cancer Coalitions Network...
Read more
Brain Tumors

Impact on Cancer Patient Organisations Worldwide in 2020 – IBTA

wordpressadmin - 0
First Coalition Connection event sees publication of report showing devastating impact of COVID-19 on cancer organisations  On 4th February 2021, the Global Cancer Coalitions Network...
Read more
Brain Tumors

The IBTA e-News January 2021

wordpressadmin - 0
Read more

LEAVE A REPLY

Please enter your comment!
Please enter your name here

Most Popular

Third COVID-19 Vaccine Earns Emergency Use Authorization Following Favorable Advisory Committee Meeting

Alzheimer’s Disease wordpressadmin - 0
The first single-dose COVID-19 vaccine was granted Emergency Use Authorization (EUA) by the FDA, according to its developer Janssen Pharmaceutical Companies of Johnson &...
Read more

Abiraterone Acetate, Apalutamide Likeliest to Improve Survival for Patients with Castration-Sensitive Prostate Cancer

Alzheimer’s Disease wordpressadmin - 0
In a comparison of systemic treatments as add-ons to androgen-deprivation therapy (ADT) for patients with metastatic castration-sensitive prostate cancer (mCSPC), abiraterone acetate (Zytiga) and...
Read more

Women of Minority Race/Ethnicity, Lower Socioeconomic Status Experience Lower Digital Breast Tomosynthesis Access

Alzheimer’s Disease wordpressadmin - 0
A cross-sectional study of digital breast tomosynthesis (DBT) screening published in JAMA Network Open indicated that women of minority race/ethnicity and lower socioeconomic status...
Read more

Michael Szarek, PhD, on the Outcomes of a Q-TWiST Analysis From the Phase 3 TIVO-3 Study

Alzheimer’s Disease wordpressadmin - 0
An analysis revealed that as a third- or fourth-line treatment for RCC, tivozanib significantly increased Q-TWiST compared with sorafenib, primarily through an increase in...
Read more
Load more

Recent Comments

A WordPress Commenter on Hello world!